Physician profile
Heather Saunders Wade
NPI 1235464652
$9,178.75
in general payments reported to CMS, 2019-2025
41 companies · $1,702 in 2025
The $1,702 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,809 · 2022: $2,220 · 2023: $2,032 · 2024: $1,415 · 2025: $1,702.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,149.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,217.50 | 2021-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $867.13 | 2021-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $826.13 | 2021-2025 | Leqvio |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $782.35 | 2021-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $629.46 | 2021-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $571.85 | 2021-2025 | Verquvo, Capvaxive |
| Esperion Therapeutics, INC. | $510.95 | 2021-2025 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $485.49 | 2022-2024 | Jardiance |
| Pfizer INC. | $400.01 | 2022-2025 | |
| Aop Health US, LLC | $304.03 | 2025 | Rapiblyk |
| Cvrx, INC. | $295.04 | 2022-2025 | Barostim Neo System |
| Sanofi-Aventis U.S. LLC | $206.77 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $182.01 | 2021-2023 | |
| Abiomed | $161.30 | 2023-2025 | Impella |
| Ancora Heart, INC. | $155.04 | 2025 | Accucinch |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Wade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.